Unknown

Dataset Information

0

Phosphorylation prevents polyglucosan transport in Lafora disease.

ABSTRACT:

SUBMITTER: Girard JM 

PROVIDER: S-EPMC3385497 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Polyglucosan body structure in Lafora disease.
| S-EPMC7266828 | biostudies-literature
Unknown Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.
| S-EPMC5578133 | biostudies-literature
Unknown Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.
| S-EPMC6240358 | biostudies-literature
Unknown AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.
| S-EPMC9294094 | biostudies-literature
Unknown Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model.
| S-EPMC10094345 | biostudies-literature
Unknown Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.
| S-EPMC8423949 | biostudies-literature
Unknown Lafora disease.
| S-EPMC5777303 | biostudies-literature
Unknown Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.
| S-EPMC10684475 | biostudies-literature
Unknown Everolimus does not prevent Lafora body formation in murine Lafora disease.
| S-EPMC5224705 | biostudies-literature
Unknown Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.
| S-EPMC6774808 | biostudies-literature